12-100404104-G-T
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_139319.3(SLC17A8):c.1120G>T(p.Ala374Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000543 in 1,614,112 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_139319.3 missense
Scores
Clinical Significance
Conservation
Publications
- nonsyndromic genetic hearing lossInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing loss 25Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC17A8 | ENST00000323346.10 | c.1120G>T | p.Ala374Ser | missense_variant | Exon 9 of 12 | 1 | NM_139319.3 | ENSP00000316909.4 | ||
| SLC17A8 | ENST00000392989.3 | c.970G>T | p.Ala324Ser | missense_variant | Exon 8 of 11 | 1 | ENSP00000376715.3 | |||
| SLC17A8 | ENST00000547922.1 | n.195G>T | non_coding_transcript_exon_variant | Exon 2 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000920 AC: 140AN: 152152Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00125 AC: 314AN: 251366 AF XY: 0.00135 show subpopulations
GnomAD4 exome AF: 0.000504 AC: 737AN: 1461842Hom.: 4 Cov.: 31 AF XY: 0.000573 AC XY: 417AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000919 AC: 140AN: 152270Hom.: 1 Cov.: 32 AF XY: 0.00126 AC XY: 94AN XY: 74454 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 25 Uncertain:2Benign:1
A heterozygous missense variation in exon 9 of the SLC17A5 gene that results in the amino acid substitution of Serine for Alanine at codon 374 was detected. The observed variant c.1120G>T (p.Ala374Ser) has a minor allele frequency of 0.2% and 0.12% in the 1000 genomes and ExAC databases respectively. The observed variant has previously been reported in a patient affected with deafness (Miyagawa et al. 2013) and is reported as a variant of uncertain significance in the ClinVar database. The in silico prediction of the variant are possibly damaging by PolyPhen-2 (HumDiv) and damaging by SIFT, LRT and MutationTaster2. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as a variant of uncertain significance. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
- -
not provided Benign:2
- -
This variant is associated with the following publications: (PMID: 23967202, 30245029) -
SLC17A8-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at